Decode
Decode49
About
What does Decode do?
Decode Age is a Bengaluru-based longevity science startup focused on studying aging at the cellular and biological level. Founded in 2021, the company develops predictive health tests and science-backed supplements aimed at improving healthspan. Their offerings include AI-based blood aging tests, gut microbiome analysis, and personalized nutrition insights.
What is Decode's valuation?
StartupHub estimates Decode's effective valuation at $6.8M (range $4.3M to $10.2M, 20% confidence), based on comparable companies in the sector.
How much funding has Decode raised?
Decode has raised a total of $2M in funding. The most recent round on record is Pre Series A.
Where is Decode headquartered?
Decode is headquartered in Bengaluru, India.
When was Decode founded?
Decode was founded in 2021.
What industry does Decode operate in?
Decode operates in Longevity, HealthTech, Biotech, Nutraceuticals, Microbiome Research, Biomarker Discovery.
How many employees does Decode have?
Decode has approximately 65 people on record.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Longevity and metabolic health platform offering personalized insights and interventions.
An AI-native platform that helps individuals plan their entire 100-year life by integrating health, money, work, and purpose.
AI-powered platform for personalized health and longevity.
A free, instant biological-age mirror that tells you how old your body really is, with no signup required.
AI-powered longevity and wellness insights based on aging hallmarks.
An entrant is a company tagged Longevity whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.